Investor Relations OTCQB: SVFC

webcast-iconWebcasts: Corporate Presentation Webcast, January 9, 2012 at 11:30 a.m. (PT)

StocksIntellicell® Biosciences Ticker Symbol for Stocks:  OTCQB: SVFC

PhoneFor Investor Relations Questions & Answers: Phone: 212-249-3050

SECwww.sec.gov – Link to Intellicell Bioscience’s SEC Listing

Corporate Summary


  • Experienced management team in regenerative medicine
  • Top tier scientific and medical advisory group
  • Ultrasound based patent pending manufacturing process
  • Addresses multiple medical treatment areas with significant unmet clinical needs such as osteoarthritis, gingival gum regeneration, sports medicine, and multiple sclerosis
  • First autologous VFC process for enhanced cellular yields without culturing cells or using enzymatic digestion

Proven Management and Seasoned Board Of Directors

    • All Filings
    • Annual
    • Quarterly
    • Current Reports
    • Proxies
    • Ownership
Filing Date Form Type Description View
Feb 14, 2013 3 Initial statement of beneficial ownership of securities htmlpdf
Jan 14, 2013 3 Initial statement of beneficial ownership of securities htmlpdf
Sep 14, 2012 3 Initial statement of beneficial ownership of securities htmlpdf
Sep 14, 2012 4 Statement of changes in beneficial ownership of securities htmlpdf
Jun 14, 2012 3 Initial statement of beneficial ownership of securities htmlpdf